Aerogen, the world leader in aerosol drug delivery continues to expand its international activities with the opening of its Middle East Commercial office in Dubai. The office will be located in Dubai Airport Freezone, Office 5EB 238, Dubai.
Headed up David Hammond, Sales Director EMEA, Aerogen has two full time staff based in the region. “I am pleased to announce the opening of our new regional office in Dubai”, says Hammond. “Aerogen has taken the decision to expand our Gulf team and open the Dubai office in order to get closer to our customers and support its growth in the Gulf region. Our Dubai office is integral part of the Aerogen growth strategy and the investment in it demonstrates Aerogen’s long-term vision to developing and supporting its customers in the region.”
Aerogen is seeing growing demand across all markets but has seen outstanding growth across the entire Gulf region. John Power, Aerogen CEO and Founder, states: “There’s a really great opportunity for us in the Middle East, it is an extremely important market for Aerogen, and we look forward to strengthening our commitment here over the coming years.”
The announcement was made in the presence of Jim Daly TD, Minister of State at the Department of Health.
To contact Aerogen in Dubai call +971 4 2288120 or email ClinicalSupportGulf@aerogen.com
Aerogen is the world’s leading medical device company specialising in the design, manufacture and commercialisation of aerosol drug delivery systems. Aerogen’s patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of critically ill patients of all ages.
Employing over 150 experienced staff, Aerogen has a strong international presence with offices in Ireland, the UK, France, Germany, China, the United States, and most recently The Middle East. Over six million patients have benefited from Aerogen technology.